CITY'S USE OF OPIOID SETTLEMENT THREATENED BY LAX OVERSIGHT, LIMITED FUNDS.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Author(s): D'Ambrosio, Amanda (AUTHOR)
  • Source:
    Crain's New York Business. 9/4/2023, Vol. 39 Issue 30, p1-1. 1p.
  • Additional Information
    • Subject Terms:
      JOHNSON & Johnson (Company); WALGREEN Co.; CVS Health Corp.; SUBSTANCE abuse treatment laws; NARCOTIC laws; FINANCING of public health; OPIOID abuse; OPIOIDS; PHARMACEUTICAL services insurance
    • Abstract:
      New York state in the next 18 years will distribute up to $2.6 billion in settlements from lawsuits against opioid manufacturers and distributors including Johnson & Johnson, CVS and Walgreens over their role in the opioid epidemic that has claimed the lives of at least 30,000 New Yorkers. At an opioid settlement fund advisory board meeting in July in Albany, leaders from local governments presented on their community's investment of opioid settlement funds. [Extracted from the article]
    • Abstract:
      Copyright of Crain's New York Business is the property of Crain Communications Inc. (MI) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)